Dose of Corticosteroids in COPD

ClinicalTrials.gov ID: NCT01742338

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT01742338. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 1:11 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Determining Optimal Dose of Corticosteroids in COPD Exacerbations: A Pilot Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

COPD (chronic obstructive pulmonary disease) is a long-lasting lung disease usually caused by long-term smoking. COPD can get worse, making people sick enough to need hospitalization. Corticosteroids are very effective and are almost always used, but nobody knows the right dose. High doses may work better but could cause more side effects than low doses. Typical treatment lengths last at least one week. This study will be comparing two common regimens: either 40mg of corticosteroids daily (low dose), or 80mg of corticosteroids daily (high dose). It is unknown which regimen works better..

Study identification

NCT ID: NCT01742338
Recruitment status: Terminated
Study type: Interventional
Phase: Phase 4
Lead sponsor: Rutgers, The State University of New Jersey; Other
Enrollment: 89 participants

Conditions and interventions

Conditions

COPD

Interventions

Low Dose Corticosteroids Drug
High Dose Corticosteroids Drug

Drug

Eligibility (public fields only)

Age range: 40 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: May 3, 2012 (Actual)
Primary completion: Mar 15, 2020 (Actual)
Completion: Mar 15, 2020 (Actual)
Last update posted: Apr 10, 2024

2012 – 2020

United States locations

U.S. sites: 2
U.S. states: 1
U.S. cities: 2

Facility	City	State	ZIP	Site status
Robert Wood Johnson University Hospital	New Brunswick	New Jersey	08901	—
University Medical Center at Princeton	Plainsboro	New Jersey	08536	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01742338, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 10, 2024 · Synced Nov 15, 2026